Share

Videos

Amgen Said To Be Near A Deal To Buy Onyx

wochit news
|
August 24, 2013 AT 10:34 AM
The biotech giant Amgen near a deal to buy Onyx Pharmaceuticals, a maker of cancer-fighting drugs, for about $125 a share. If a transaction is completed, it would be only the latest in the health care industry. One focus for drug makers looking to strike deals is buying new cancer drugs, which can fetch high prices.